Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125830421 | 12583042 | 1 | I | 20160718 | 20160722 | 20160722 | EXP | IE-UCBSA-2016026887 | UCB | 4.00 | YR | M | Y | 0.00000 | 20160722 | CN | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125830421 | 12583042 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | UNK | U | U | 21035 | |||||||||
| 125830421 | 12583042 | 2 | C | EPILIM | VALPROATE SODIUM | 1 | UNK | U | 0 | ||||||||||
| 125830421 | 12583042 | 3 | C | ZONEGRAN | ZONISAMIDE | 1 | UNK | U | 0 | ||||||||||
| 125830421 | 12583042 | 4 | C | Frisium | CLOBAZAM | 1 | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125830421 | 12583042 | 1 | Seizure |
| 125830421 | 12583042 | 2 | Seizure |
| 125830421 | 12583042 | 3 | Seizure |
| 125830421 | 12583042 | 4 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125830421 | 12583042 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125830421 | 12583042 | Autism | |
| 125830421 | 12583042 | Developmental delay | |
| 125830421 | 12583042 | Drug ineffective | |
| 125830421 | 12583042 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |